Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Squamous Cell Carcinoma of Head and Neck × Interviews as Topic × 90 days × Clear all

Sponsor

Conditions

Breast Neoplasms 10 Neoplasms 9 Hematopoietic and Lymphatic System Neoplasm 7 Lung Neoplasms 5 Colorectal Neoplasms 5 Prostatic Neoplasms 4 Urinary Bladder Neoplasms 3 Ovarian Neoplasms 3 Malignant Solid Neoplasm 3 Obesity-Related Malignant Neoplasm 2 Carcinoma, Non-Small-Cell Lung 2 Vulvar Neoplasms 1 Vaginal Neoplasms 1 Uterine Cervical Neoplasms 1 Urinary Incontinence 1 Triple Negative Breast Neoplasms 1 Sarcoma 1 Pyloric Stenosis, Hypertrophic 1 Papillomavirus Infections 1 Pancreatic Neoplasms 1 Neuroblastoma 1 Neoplasm Metastasis 1 Motor Activity 1 Mental Disorders 1 Lymphoma, Non-Hodgkin 1 Lymphoma 1 Leukemia, Myeloid, Chronic-Phase 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Leukemia 1 Laryngeal Diseases 1

Interventions

pembrolizumab 55 Cisplatin 35 Cetuximab 26 Carboplatin 24 Radiotherapy 18 Radiotherapy, Intensity-Modulated 17 Magnetic Resonance Spectroscopy 16 Specimen Handling 14 Paclitaxel 14 Nivolumab 14 Docetaxel 14 Platinum 8 Fluorouracil 8 1,2-diaminocyclohexaneplatinum II citrate 8 Biopsy 6 (225)Ac-DOTA-c(RGDyK) 6 atezolizumab 5 Radiation 5 Ipilimumab 5 Drug Therapy 5 durvalumab 4 cemiplimab 4 Taxes 4 Standard of Care 4 Radiosurgery 4 Immunoglobulin G 4 Immune Checkpoint Inhibitors 4 Cyclophosphamide 4 Chemoradiotherapy 4 toripalimab 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡